The ROC n’ role of the multiplex assay for early detection of ovarian cancer
The sensitivity and specificity of CA125 for early detection of ovarian cancer is improved when analysed in combination with novel biomarkers, although further validation studies are required to confirm the clinical utility of the multiplex [more]